Reishi is one of the oldest medicinal mushrooms in continuous use anywhere in the world. The oldest Chinese medical text, more than 2,000 years old, already mentions it. That history produces a problem for anyone trying to figure out how much to take today: traditional dosing guidance lives in texts that were never trying to match the 21st-century clinical trial model, and modern clinical trials have used a much narrower range of preparations than tradition covers.

Here is what the research actually supports, what the trials have used, and how to match a product to a goal.

One upfront note before we get into numbers: reishi is not lion’s mane. The use case is different, the timing is different, and the drug interactions are more serious. The anticoagulant effects of reishi are real, not theoretical, and the post spends more time on safety than the lion’s mane equivalent for that reason. If you are on blood thinners or scheduled for surgery, read the safety section before deciding to start.

The evidence-based dose range

Three reference points define the practical reishi dose range.

Tang et al. 2005 (Journal of Medicinal Food): 1,800 mg of Ganopoly polysaccharide extract three times daily, for a total of 5,400 mg per day, taken for 8 weeks. Population: 132 Chinese patients with neurasthenia (a diagnostic category defined by fatigue, malaise, irritability, and sleep disturbance). Result: significantly greater reduction in fatigue and improvement in sense of well-being compared to placebo. The Ganopoly group saw a 28.3% reduction in fatigue from baseline versus 20.1% for placebo, and the between-group differences were statistically significant [1].

Gao et al. Ganopoly diabetes trials: 1,800 mg three times daily (same 5,400 mg per day total) reduced postprandial glucose values in patients with type 2 diabetes. This is the same dose that worked for neurasthenia, which tells you something about the practical ceiling of what clinical research has tested [2].

Klupp et al. 2016 (Scientific Reports): This is the null result that honest reishi writing has to include. 16 weeks of Ganoderma lucidum supplementation did not produce meaningful improvements in HbA1c, fasting glucose, lipid parameters, or blood pressure in adults with type 2 diabetes and metabolic syndrome [3]. Reishi did not rescue metabolic syndrome at clinical doses over a substantial duration.

Three other data points fill in the range:

Pharmacopoeia of the People’s Republic of China: recommends 6 to 12 g of reishi extract daily as the traditional reference range.

Pazzi et al. 2020 (Healthcare): 6 g per day of reishi in women with fibromyalgia, for effects on mood and quality of life.

Noguchi et al. 2008 (Asian Journal of Andrology): Ganoderma ethanol extract for men with lower urinary tract symptoms, with the ethanol extract providing the triterpenoid-rich fraction.

The practical range that emerges is 1,500 to 5,400 mg per day of polysaccharide extract or 6 to 12 g per day of whole mushroom powder. The form affects what the number means, which is the next section.

Why the form matters even more than for lion’s mane

With lion’s mane, the fruiting-body-versus-mycelium distinction is the main variable. With reishi, there are actually four distinct product forms in common use, and each has a different chemistry:

Whole fruiting body powder. Dried and milled reishi fruit. Traditional Chinese Medicine tradition uses this form or its decoction. The Chinese Pharmacopoeia 6 to 12 g daily range assumes whole mushroom powder or decoction.

Hot water extract (polysaccharide-rich). The form used in most of the Ganopoly trials. Hot water pulls beta-glucans and other polysaccharides, which are the immune-modulating and anti-fatigue compounds studied in Tang 2005. This is the most common form in modern Western supplements and the one with the most direct clinical evidence for fatigue and well-being outcomes.

Ethanol extract (triterpene-rich). The form Noguchi 2008 used. Reishi contains ganoderic acids and other triterpenes that are alcohol-soluble and not captured in a hot-water-only extract. These compounds are responsible for reishi’s bitter taste and for some of the documented cardiovascular and anti-cancer mechanisms. If your reishi product does not taste bitter, it probably is not capturing the triterpenes.

Spore powder and cracked spore products. Reishi spores contain a different chemical profile than the fruiting body, with higher triterpene density in some analyses. The Zhao 2012 study on breast cancer fatigue used Ganoderma spore powder [4]. However, spore powder has also been documented to artificially elevate the CA72-4 tumor marker, which is a diagnostic problem if you are being monitored for certain cancers [5]. Spore products are a legitimate category but not interchangeable with fruiting body products.

The practical result: “1,000 mg of reishi” means something very different depending on form. A gram of whole mushroom powder is not the same as a gram of concentrated hot water extract, which is not the same as a gram of spore powder. If you want to understand the general principles behind mushroom extraction, Mushroom Dual Extraction: Why It Matters covers why dual extraction (water plus alcohol) captures a more complete compound profile than either method alone.

Reishi is also one of the mushrooms where sloppy sourcing matters most. Mycelium on grain products for reishi have the same quality issues as for lion’s mane: the capsule contains mostly grain starch rather than actual fungal bioactives.

Dosing by goal

This is where reishi’s evidence base diverges from lion’s mane. Each goal has a different supporting research profile.

Fatigue and well-being. The strongest evidence in the reishi literature. Tang 2005 used 5,400 mg per day of polysaccharide extract for 8 weeks. If you are buying reishi primarily for the “takes the edge off life” effect that most reishi marketing describes, this is the trial dose to match. In practice, starting at 1,500 to 2,000 mg per day of a quality polysaccharide extract for 4 weeks and then stepping up if needed is reasonable. The Tang 2005 cohort saw measurable effects, but they were modest, not dramatic.

Sleep support. This is the most common reason people actually buy reishi, and the clinical evidence here is weaker than the marketing suggests. Most of the sleep data is preclinical (rodent studies showing increased sleep time and reduced sleep latency). Human trials are older, smaller, and published primarily in Chinese-language journals. The 1,500 to 2,000 mg per day polysaccharide extract range is what the existing human evidence has used. Taking reishi specifically for sleep is not wrong, but expectations should be tempered by the fact that the large, well-designed human sleep trials do not exist yet.

Immune support. Polysaccharides and beta-glucans in reishi have well-documented immune-modulating activity in preclinical research, and the Cochrane systematic review of reishi in cancer treatment found that G. lucidum simultaneously increased CD3, CD4, and CD8 percentages in cancer patients by 3 to 4 percent as an adjunct to chemotherapy [6]. If immune support is your goal, 1,500 to 3,000 mg per day of a polysaccharide-rich hot water extract is the evidence-based range.

Cancer adjunct support. This is a medical decision, not a supplement decision. Do not self-prescribe reishi as a cancer treatment or adjunct to chemotherapy without explicit oversight from your oncology team. The Cochrane review concluded that evidence was insufficient to justify reishi as a first-line cancer treatment but noted potential adjunct value when combined with conventional therapy [6]. Doses in cancer adjunct trials ranged from 1,800 to 5,400 mg per day of polysaccharide extract.

Cardiovascular and metabolic syndrome. This is where the null result from Klupp 2016 matters. A well-designed 16-week trial did not find meaningful improvements in HbA1c, lipids, or blood pressure [3]. Reishi marketing will claim cardiovascular benefits. The best-quality RCT evidence does not support those claims at the doses tested.

General health maintenance. The Chinese Pharmacopoeia 6 to 12 g of whole mushroom powder daily is the traditional reference. In extract form, 1,500 to 2,000 mg per day is a reasonable maintenance dose.

When to take it

Unlike lion’s mane, which has no clear timing preference, reishi genuinely benefits from evening administration for most users.

The reason is mechanistic. Reishi contains compounds that modulate the stress response and have mild tranquilizing effects. If you are taking it for fatigue during the day and it is mildly sedating, that is a problem. If you are taking it for sleep or stress at night, the timing is doing useful work.

Practical approach:

• If the goal is sleep or stress reduction, take the full dose 60 to 90 minutes before bed.
• If the goal is immune support or cancer adjunct, splitting the dose between morning and evening is fine.
• If you find reishi makes you groggy during the day, move all of it to evening.
• If you are combining reishi with other supplements like cordyceps or lion’s mane, do not stack reishi with them in the same morning dose. Take the energizing mushrooms in the morning and reishi at night.

Consistency matters more than precise timing. A dose taken within a 2-hour window every evening produces more predictable effects than the same total dose taken haphazardly.

How long before you notice anything

The Tang 2005 trial measured outcomes at 8 weeks. That is the primary published human evidence on duration. Traditional Chinese Medicine describes reishi as a tonic that is taken over months to years, not as an acute intervention.

Practical timeline for common goals:

• Sleep onset effects: some users report changes within 1 to 2 weeks. Not reliable across users.
• Fatigue and well-being: measurable changes in trials took 8 weeks of daily use. Most users will not notice anything until 4 to 6 weeks in.
• Immune markers: cancer adjunct trials measured immune cell changes at 4 to 12 weeks.

If you have taken reishi at a clinical-range dose for 6 to 8 weeks and noticed nothing, the product is either underdelivering or reishi is not producing a noticeable effect for your specific situation. Before concluding reishi does not work, verify the form (quality hot water or dual extract, not raw powder or mycelium-on-grain) and check that the dose matches the trial range.

Safety and side effects

Reishi has a longer safety track record than most supplements in active use. Two thousand years of documented human consumption and modern clinical trials lasting up to 16 weeks both support a strong baseline safety profile. That said, the following side effects are documented and worth knowing.

Mild GI symptoms. Nausea, stomach upset, and loose stool in the first 1 to 2 weeks. Usually resolves as the gut adjusts.

Dizziness and dry mouth. Less common but reported in the Tang 2005 cohort and other trials.

Skin rash. Rare allergic or sensitization reactions.

Dry throat and nasal dryness. Occasionally reported with long-term use, possibly related to the triterpenoid content.

Rare hepatotoxicity. The LiverTox database (maintained by the National Institute of Diabetes and Digestive and Kidney Diseases) has documented rare cases of clinically apparent liver injury associated with reishi products. This appears to be product-specific rather than reishi-intrinsic, meaning contaminated or adulterated products are the likely culprit rather than reishi itself. This is a reason to buy from brands that publish third-party certificates of analysis rather than from the cheapest Amazon option.

Liver function monitoring. For anyone taking reishi long-term, an annual liver panel is a reasonable precaution, especially if you are on any other medications metabolized by the liver. If you have existing liver disease, discuss reishi with your hepatologist before starting.

Duration limits in the formal safety data. Reishi mushroom extract is considered possibly safe when used for up to one year. Powdered whole reishi mushroom is considered possibly safe when used for up to 16 weeks. Longer-term formal safety data is limited.

Drug interactions to know about

This is the section where reishi differs most from lion’s mane, and where being honest about the risks matters.

Anticoagulants and antiplatelets. This is the main one. Reishi has documented anticoagulant and antiplatelet activity. A 2005 randomized controlled trial published in Anesthesia and Analgesia specifically tested reishi’s effects on platelet function in healthy volunteers [7]. A 2021 systematic review of warfarin interactions in the British Journal of Clinical Pharmacology identified Ganoderma lucidum as one of the herbs with documented potential to interact with warfarin [8]. Reishi extracts may prolong INR, PT, and APTT.

If you take warfarin, apixaban, rivaroxaban, dabigatran, clopidogrel, aspirin as an anticoagulant, or any other blood thinner, do not start reishi without explicit physician oversight and likely INR monitoring. This is not theoretical. Memorial Sloan Kettering lists anticoagulants and antiplatelets as a direct interaction category for reishi.

Upcoming surgery. Standard clinical guidance is to stop reishi at least 2 weeks before any scheduled surgical procedure, because of the bleeding risk. This includes dental surgery, outpatient procedures, and anything where platelet function matters.

Immunosuppressants. Reishi has immunomodulatory effects through its polysaccharide content, particularly on NK cell activity and CD3/CD4/CD8 populations. If you take immunosuppressants after organ transplant or for autoimmune conditions (tacrolimus, cyclosporine, mycophenolate, methotrexate, biologics), consult your prescribing physician before adding reishi.

Diabetes medications. Reishi may lower blood glucose modestly. If you take insulin or oral diabetes medications, monitor blood sugar more closely during the first month to catch any unexpected drops.

Antihypertensives. Reishi may have mild blood-pressure-lowering effects. If you take blood pressure medication, monitor during the first month.

Chemotherapy and active cancer treatment. Do not combine reishi with active chemotherapy without explicit oncology team oversight. Additionally, reishi spore powder has been documented to artificially elevate the CA72-4 tumor marker, which is used to monitor several cancer types including gastrointestinal, ovarian, endometrial, and lung cancers [5]. If you are being monitored by CA72-4 and your oncologist does not know you are taking reishi spore powder, you could generate a false alarm.

Cytochrome P450 interactions. Reishi polysaccharides have been shown to inhibit CYP2E1, CYP1A2, and CYP3A in vitro. The clinical significance is not well established in humans, but this means reishi has the theoretical potential to affect the metabolism of drugs processed by these enzymes, which is a substantial list including many psychiatric medications, statins, and immunosuppressants. If you are on medications with narrow therapeutic indices, your pharmacist should know you are taking reishi.

Pregnancy, nursing, and children

Reishi has not been formally evaluated for safety during pregnancy or breastfeeding. The default clinical position for unvalidated supplements during pregnancy is to avoid them unless a physician specifically recommends otherwise. The anticoagulant effects are particularly concerning in late pregnancy given bleeding risk. Do not give reishi to children without pediatric oversight.

What affects whether your dose actually works

The same quality framework that applies to every mushroom supplement applies to reishi, with two reishi-specific considerations:

Beta-glucan content. Quality reishi fruiting body extract should contain 15 to 30 percent beta-glucans by dry weight when tested by proper enzymatic assay. Reishi tends to run lower in beta-glucan content than lion’s mane fruiting body because the tissue is woodier. A reishi product that claims “30 percent polysaccharides” without specifying beta-glucans is using the looser polysaccharide category, which includes non-bioactive sugars. I cover this distinction in What Are Beta-Glucans?.

Triterpene content. For reishi specifically, triterpenoid content is a secondary quality marker that water-only extracts cannot capture. A genuine dual-extract reishi product or a product with a separate ethanol extract component will have a characteristic bitter taste. If your reishi product is not bitter, the triterpene fraction is probably absent or minimal.

Third-party testing. A product that publishes a certificate of analysis showing beta-glucan percentage, heavy metal limits, and contamination testing is verifying what it claims. Given the rare but documented liver toxicity reports with reishi, this is a supplement category where sourcing matters more than average.

Source species. Technical point worth knowing: the species name Ganoderma lucidum is commonly used for reishi products, but commercial East Asian reishi is often actually Ganoderma lingzhi, a closely related species separated taxonomically in recent years. The research literature uses both names, sometimes interchangeably. For practical purposes, both species produce similar bioactive compounds and are used interchangeably in supplements. Some European cultivation does use the original G. lucidum. A product that cannot tell you what species or strain it is using is a transparency issue.

Mycelium-on-grain products. Reishi mycelium-on-grain has the same quality issues as lion’s mane mycelium-on-grain. The rice substrate dilutes the actual fungal bioactive content, and the beta-glucan percentage on the label (if listed) often includes the alpha-glucan starch from the grain.

Frequently asked questions

The honest summary

Effective daily doses of reishi based on human clinical trials fall in two ranges. For concentrated polysaccharide extract (the Ganopoly form used in most modern trials), 1,500 to 5,400 mg per day. For whole mushroom powder (the traditional form), 6 to 12 g per day. Evening administration is generally preferred because of the mild calming effects. At least 6 to 8 weeks of daily use before judging results.

The strongest human evidence is for fatigue and well-being in neurasthenia. The null result on metabolic syndrome from Klupp 2016 is real and worth knowing. Immune modulation evidence exists but is mostly in cancer-adjunct contexts, not in healthy-person trials.

Safety is generally good, with two important exceptions: the anticoagulant interaction is real and documented, and rare hepatotoxicity cases exist. Stop reishi at least 2 weeks before any surgery. Do not combine with blood thinners without physician oversight. Talk to your oncology team before adding it to any active cancer treatment.

If you are picking your first reishi product, start with a 1,500 to 2,000 mg per day dose of a hot water polysaccharide extract (or a dual extract if you want the triterpenes too) from a brand that publishes a certificate of analysis, take it 60 to 90 minutes before bed, and give it 6 to 8 weeks before evaluating. That is the most evidence-supported approach.

References

[1] Tang W, Gao Y, Chen G, Gao H, Dai X, Ye J, Chan E, Huang M, Zhou S. A randomized, double-blind and placebo-controlled study of a Ganoderma lucidum polysaccharide extract in neurasthenia. Journal of Medicinal Food. 2005;8(1):53-58. PubMed

[2] Gao Y, Lan J, Dai X, Ye J, Zhou S. A phase I/II study of Ling Zhi mushroom Ganoderma lucidum (W.Curt.:Fr.)Lloyd (Aphyllophoromycetideae) extract in patients with type II diabetes mellitus. International Journal of Medicinal Mushrooms. 2004;6(1):33-39.

[3] Klupp NL, Kiat H, Bensoussan A, Steiner GZ, Chang DH. A double-blind, randomised, placebo-controlled trial of Ganoderma lucidum for the treatment of cardiovascular risk factors of metabolic syndrome. Scientific Reports. 2016;6:29540. PubMed

[4] Zhao H, Zhang Q, Zhao L, Huang X, Wang J, Kang X. Spore Powder of Ganoderma lucidum Improves Cancer-Related Fatigue in Breast Cancer Patients Undergoing Endocrine Therapy: A Pilot Clinical Trial. Evidence-Based Complementary and Alternative Medicine. 2012;2012:809614. PubMed

[5] Yan B, Meng X, Shi J, Qin Z, Wei P, Lao L. Ganoderma lucidum spore induced CA72-4 elevation in gastrointestinal cancer: a five-case report. Integrative Cancer Therapies. 2014;13(2):161-166.

[6] Jin X, Ruiz Beguerie J, Sze DM, Chan GC. Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane Database of Systematic Reviews. 2016;4(4):CD007731. Cochrane

[7] Kwok Y, Ng KF, Li CC, Lam CC, Man RY. A prospective, randomized, double-blind, placebo-controlled study of the platelet and global hemostatic effects of Ganoderma lucidum (Ling-Zhi) in healthy volunteers. Anesthesia and Analgesia. 2005;101(2):423-426.

[8] Tan CSS, Lee SWH. Warfarin and food, herbal or dietary supplement interactions: A systematic review. British Journal of Clinical Pharmacology. 2021;87(2):352-374. Wiley

Not medical advice. For informational purposes only. Consult your physician or pharmacist before starting reishi, particularly if you take prescription medications, are pregnant or nursing, have a scheduled surgery, or have an underlying medical condition. See Medical Disclaimer.